Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
about
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNRReplication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexesPotential cellular receptors involved in hepatitis C virus entry into cellsScavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles.Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant PatientsViral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate InteractionHepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particlesRapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis CStudying Hepatitis C Virus: Making the Best of a Bad VirusScavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic CellsHepatitis C Virus Is a Weak Inducer of Interferon Alpha in Plasmacytoid Dendritic Cells in Comparison with Influenza and Human Herpesvirus Type-1Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral EntryCD81 is required for hepatitis C virus glycoprotein-mediated viral infectionCapitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designInhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2.Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.Topology of hepatitis C virus envelope glycoproteins.Development of hepatitis C virus vaccines: challenges and progress.NS2 is dispensable for efficient assembly of hepatitis C virus-like particles in a bipartite trans-encapsidation system.Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradationNeutralizing antibodies in hepatitis C virus infection.Hepatitis C virus comes full circle: production of recombinant infectious virus in tissue culture.Hepatitis C virus entry: molecular biology and clinical implications.New therapeutic opportunities for hepatitis C based on small RNA.Hepatitis C virus infection: in vivo and in vitro models.Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.A vaccinia replication system for producing recombinant hepatitis C virus.Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody.HCV entry and neutralizing antibodies: lessons from viral variants.Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles.The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
P2860
Q24296260-C4FE23D9-6E28-446C-9A2B-948E24B43DDBQ24551041-3BEA5AF5-8382-4ED5-BC23-416D60728FAFQ24611792-3C874AD9-3AD0-42C0-ADAA-C447F2E9DC69Q24673768-6BDAE465-A585-4A41-80FF-AE2A75811A8AQ24795289-B558028D-54CC-4CE2-905E-4FE4D4B9E3A0Q27469468-F622956A-B0DB-446F-95AE-DD532EC57BBAQ27472891-354829E1-7234-4374-A44C-17DC21CF2129Q27472900-5AE4AD5A-42ED-454B-8E29-7013B4BFB59FQ27472909-DBDDF79B-D776-4310-9B16-6574FF0E5DCBQ27473046-264F8174-C439-44FD-BCAB-981975AE4BD1Q27477606-A1848286-21B7-4D03-B6EC-1BD47CC096E9Q27477687-B3E3C192-517F-41BE-A06F-DFC53401E01CQ27478257-2675A296-2D5E-40EC-97E2-4592FC48BCEEQ27481034-AD0D16F8-90FB-49CA-B566-944471B79ADEQ27485559-17180B29-0F01-4E8D-BC91-944D32998B41Q27487765-41B7DD97-EBC7-4DB1-A463-756E718ABAEFQ27490785-3AFC1157-9CC9-49FE-989A-BE114F1DF725Q29619745-2F4744F9-52A3-4626-941D-B6BA4DDDF8FEQ30374314-36FD23C6-20F6-44B7-A52B-D345835552EEQ30767073-0142B4DC-DBF9-4672-81A5-D9D87ED145ACQ30969962-A5487448-2EA4-4D69-802C-C82DF479D4CDQ33691856-5FF9BA0D-55B2-43BD-B37C-4BB6700C3A4BQ34016463-5939995B-B9FB-4410-83F9-213A7ADB431AQ34207847-9519E420-A64D-4322-BD06-89130DF3D739Q34254941-2C080B56-2631-431B-A493-A3F05BC1A7E1Q34366406-4A9045DF-FEDD-4925-80FD-556AA952D942Q34558519-FFAB9FC6-1305-4BC4-9706-1A289F3F234AQ35704771-92BA74F3-3D46-4F86-B280-BC6B7DA50109Q36179699-EB572F20-A47D-4F88-BB89-52E98DFBBB0EQ36326835-785B0DC8-075A-458C-BFB5-A4DF59D4D9F7Q36581588-1971824B-7A1B-4ECA-B6FC-C6551D6FA187Q36921336-30101A4C-08F8-4EEF-828F-E94840895C57Q36980739-A9B2C968-C5C4-4329-9B27-0C62EC9A56ECQ37417839-4793CA4F-5884-456A-8F0C-E8AB04C3DE84Q38352468-5223B71E-23A8-4231-9208-814AF7F11B01Q39605783-60D8FC37-EDA4-4659-9225-5532EDECC578Q39809922-7464191C-C0B7-469A-A17D-5287963E9027Q39974049-6B55687A-50A2-4F14-94D7-AE54B69506AAQ40097907-1429E2BE-4756-4F94-A40C-F1CEDA24C404Q40141383-A7F2D129-B522-4506-8418-21485C6B5BC6
P2860
Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Binding of Hepatitis C Virus-L ...... 7C to Defined Human Cell Lines
@nl
Binding of hepatitis C virus-l ...... C to defined human cell lines.
@ast
Binding of hepatitis C virus-l ...... C to defined human cell lines.
@en
type
label
Binding of Hepatitis C Virus-L ...... 7C to Defined Human Cell Lines
@nl
Binding of hepatitis C virus-l ...... C to defined human cell lines.
@ast
Binding of hepatitis C virus-l ...... C to defined human cell lines.
@en
prefLabel
Binding of Hepatitis C Virus-L ...... 7C to Defined Human Cell Lines
@nl
Binding of hepatitis C virus-l ...... C to defined human cell lines.
@ast
Binding of hepatitis C virus-l ...... C to defined human cell lines.
@en
P2093
P2860
P1433
P1476
Binding of hepatitis C virus-l ...... C to defined human cell lines.
@en
P2093
Bettina Klumpp
Erik Depla
Heidi Barth
Hubert E Blum
Sabine Wellnitz
Susumu Ito
Thomas F Baumert
P2860
P304
P356
10.1128/JVI.76.3.1181-1193.2002
P577
2002-02-01T00:00:00Z